CLINICAL_TRIALS
trial_result
· 2024-01-23
Clinical Trial Update: A Study of OV101 in Individuals With Fragile X Syndrome [Phase 2]
Summary
Phase 2 clinical trial of OV101 in Fragile X Syndrome has completed and results were posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Healx AI | Conditions: Fragile X Syndrome (FXS) | Phase 2 | Status: COMPLETED | Results posted: 2024-01-23